Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma. (Q53537025)
Jump to navigation
Jump to search
scientific article published in September 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma. |
scientific article published in September 2007 |
Statements
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma. (English)
Stephen A Boorjian
Matthew I Milowsky
Jodi Kaplan
Martin Albert
Marta Vallee Cobham
Deirdre M Coll
Gary Shelton
Daniel Petrylak
Lorraine J Gudas
David M Nanus
1 September 2007
30
6
655-662